The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Genetox completes Phase 3 trial of Botanyu 100 Units with 326 participants

Nov 5, 2026 02:16 (5h ago)

Verifying

Genetox completed medication administration and follow-up observations for its Botanyu 100 Units Phase 3 trial.
326 participants received the investigational drug during the efficacy and safety study.
Genetox plans a termination report next month and a January 2027 approval application.